Fig. 2From: Optimal empiric treatment for KPC-2-producing Klebsiella pneumoniae infections in critically ill patients with normal or decreased renal function using Monte Carlo simulationThe MIC distribution of FOS in monotherapy or combination with TGC or CMS against 136 KPC-producing. Klebsiella pneumoniae, and probability of target attainment (PTA) of 24 AUC24/MIC for FOS dosing regimens in critically. Ill elderly patients with normal renal function (Left) and renal impairment (right). The dotted line indicates the PTA of 0.9. FOS, fosfomycin; TGC, tigecycline; CST, colistinBack to article page